US Stock MarketDetailed Quotes

NMRA Neumora Therapeutics

Watchlist

10.910
-0.800-6.83%

Trading Nov 5 12:54 ET

1.75BMarket Cap-6365P/E (TTM)

Neumora Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-81.03%-56.16M

-30.01%-42.96M

-42.11%-163.28M

-69.41%-51.44M

-85.43%-47.77M

-16.71%-31.02M

-2.66%-33.04M

-52.34%-114.9M

-3.45%-30.37M

-49.30%-25.76M

Net income from continuing operations

-52.30%-58.7M

-50.80%-53.72M

-80.23%-235.93M

-286.31%-108.73M

-80.71%-53.03M

-26.90%-38.54M

17.23%-35.63M

44.84%-130.9M

-4.36%-28.15M

83.52%-29.34M

Operating gains losses

----

-988.68%-577K

---316K

---16K

Depreciation and amortization

-6.43%160K

0.00%158K

12.46%668K

12.93%166K

18.49%173K

11.04%171K

7.48%158K

10.41%594K

12.21%147K

-2.67%146K

Other non cash items

-4.47%812K

-2.83%791K

338.98%67.38M

8,017.15%64.86M

-16.44%859K

181.46%850K

-93.84%814K

-90.29%15.35M

-0.50%799K

-99.34%1.03M

Change In working capital

-277.22%-9.03M

1,062.14%3.59M

-28.08%-8.9M

-153.27%-13.11M

-314.95%-1.19M

194.62%5.1M

107.62%309K

-623.00%-6.95M

-15.56%-5.18M

-75.38%555K

-Change in prepaid assets

-129.56%-9.74M

-6.45%7.35M

-214.25%-11.4M

-293.18%-8.13M

-642.46%-6.89M

-3,219.12%-4.24M

1,121.85%7.86M

-60.53%-3.63M

8.98%-2.07M

-37.08%-928K

-Change in payables and accrued expense

-84.97%1.53M

56.16%-2.96M

305.96%5.91M

-203.85%-4.07M

207.69%6.57M

466.28%10.16M

37.03%-6.75M

-149.41%-2.87M

133.39%3.92M

-32.43%2.13M

-Change in other current assets

----

--0

----

137.48%1.37M

-72.46%-6.25M

-1,080.00%-49K

-Change in other current liabilities

-0.24%-822K

-0.12%-802K

-86.36%-3.4M

-16.90%-913K

-44.35%-869K

-310.00%-820K

-229.63%-801K

-117.12%-1.83M

-194.72%-781K

-159.48%-602K

Cash from discontinued investing activities

Operating cash flow

-81.03%-56.16M

-30.01%-42.96M

-42.11%-163.28M

-69.41%-51.44M

-85.43%-47.77M

-16.71%-31.02M

-2.66%-33.04M

-52.34%-114.9M

-3.45%-30.37M

-49.30%-25.76M

Investing cash flow

Cash flow from continuing investing activities

-11.72%21.26M

-5,424.85%-150M

138.32%64.39M

270.32%13.68M

42.66%23.82M

126.44%24.08M

103.29%2.82M

-20,464.63%-168.01M

-4,171.28%-8.03M

3,151.74%16.69M

Net PPE purchase and sale

--0

77.10%-117K

-91.30%-44K

71.54%-37K

--0

79.55%-36K

37.45%-511K

87.77%-23K

76.23%-130K

Net investment purchase and sale

-11.72%21.26M

-5,330.49%-149.23M

144.72%69.09M

328.69%18.31M

41.78%23.85M

126.49%24.08M

103.94%2.85M

---154.5M

---8.01M

--16.82M

Net other investing changes

--0

---775K

64.69%-4.59M

----

---13M

--0

Cash from discontinued investing activities

Investing cash flow

-11.72%21.26M

-5,424.85%-150M

138.32%64.39M

270.32%13.68M

42.66%23.82M

126.44%24.08M

103.29%2.82M

-20,464.63%-168.01M

-4,171.28%-8.03M

3,151.74%16.69M

Financing cash flow

Cash flow from continuing financing activities

808.90%2.65M

1,726.73%1.85M

100.39%231.94M

-101.79%-481K

166.15%232.02M

-85.98%292K

128.77%101K

-60.57%115.74M

7,595.25%26.83M

-70.14%87.18M

Net common stock issuance

----

--232.88M

---491K

----

--0

----

Net preferred stock issuance

----

--0

----

-61.46%112.22M

39,738.10%24.97M

----

Proceeds from stock option exercised by employees

556.93%2.65M

1,562.16%1.85M

-33.13%2.86M

-49.85%830K

949.31%1.51M

-82.50%404K

-32.32%111K

70.23%4.27M

95.63%1.66M

-80.62%144K

Net other financing activities

----

-411.29%-3.8M

-498.06%-820K

-1,262.86%-2.86M

50.22%-112K

98.06%-10K

34.79%-744K

--206K

---210K

Cash from discontinued financing activities

Financing cash flow

808.90%2.65M

1,726.73%1.85M

100.39%231.94M

-101.79%-481K

166.15%232.02M

-85.98%292K

128.77%101K

-60.57%115.74M

7,595.25%26.83M

-70.14%87.18M

Net cash flow

Beginning cash position

-13.18%184.14M

54.93%375.25M

-40.83%242.21M

62.94%413.5M

16.95%205.43M

-27.18%212.08M

-40.83%242.21M

113.10%409.37M

-42.23%253.77M

6.40%175.66M

Current changes in cash

-384.80%-32.25M

-534.44%-191.11M

179.59%133.05M

-230.76%-38.25M

166.39%208.07M

94.24%-6.65M

74.50%-30.12M

-176.94%-167.17M

61.33%-11.56M

-71.51%78.11M

End cash Position

-26.06%151.89M

-13.18%184.14M

54.93%375.25M

62.94%413.5M

16.95%205.43M

-27.18%212.08M

-40.83%242.21M

-42.23%253.77M

Free cash flow

-81.03%-56.16M

-29.86%-42.96M

-41.58%-163.4M

-69.42%-51.49M

-84.64%-47.81M

-15.92%-31.02M

-2.21%-33.08M

-51.38%-115.41M

-2.87%-30.39M

-48.19%-25.89M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-81.03%-56.16M	-30.01%-42.96M	-42.11%-163.28M	-69.41%-51.44M	-85.43%-47.77M	-16.71%-31.02M	-2.66%-33.04M	-52.34%-114.9M	-3.45%-30.37M	-49.30%-25.76M
Net income from continuing operations	-52.30%-58.7M	-50.80%-53.72M	-80.23%-235.93M	-286.31%-108.73M	-80.71%-53.03M	-26.90%-38.54M	17.23%-35.63M	44.84%-130.9M	-4.36%-28.15M	83.52%-29.34M
Operating gains losses	----	----	----	----	----	----	----	-988.68%-577K	---316K	---16K
Depreciation and amortization	-6.43%160K	0.00%158K	12.46%668K	12.93%166K	18.49%173K	11.04%171K	7.48%158K	10.41%594K	12.21%147K	-2.67%146K
Other non cash items	-4.47%812K	-2.83%791K	338.98%67.38M	8,017.15%64.86M	-16.44%859K	181.46%850K	-93.84%814K	-90.29%15.35M	-0.50%799K	-99.34%1.03M
Change In working capital	-277.22%-9.03M	1,062.14%3.59M	-28.08%-8.9M	-153.27%-13.11M	-314.95%-1.19M	194.62%5.1M	107.62%309K	-623.00%-6.95M	-15.56%-5.18M	-75.38%555K
-Change in prepaid assets	-129.56%-9.74M	-6.45%7.35M	-214.25%-11.4M	-293.18%-8.13M	-642.46%-6.89M	-3,219.12%-4.24M	1,121.85%7.86M	-60.53%-3.63M	8.98%-2.07M	-37.08%-928K
-Change in payables and accrued expense	-84.97%1.53M	56.16%-2.96M	305.96%5.91M	-203.85%-4.07M	207.69%6.57M	466.28%10.16M	37.03%-6.75M	-149.41%-2.87M	133.39%3.92M	-32.43%2.13M
-Change in other current assets	----	----	--0	--0	----	----	----	137.48%1.37M	-72.46%-6.25M	-1,080.00%-49K
-Change in other current liabilities	-0.24%-822K	-0.12%-802K	-86.36%-3.4M	-16.90%-913K	-44.35%-869K	-310.00%-820K	-229.63%-801K	-117.12%-1.83M	-194.72%-781K	-159.48%-602K
Cash from discontinued investing activities
Operating cash flow	-81.03%-56.16M	-30.01%-42.96M	-42.11%-163.28M	-69.41%-51.44M	-85.43%-47.77M	-16.71%-31.02M	-2.66%-33.04M	-52.34%-114.9M	-3.45%-30.37M	-49.30%-25.76M
Investing cash flow
Cash flow from continuing investing activities	-11.72%21.26M	-5,424.85%-150M	138.32%64.39M	270.32%13.68M	42.66%23.82M	126.44%24.08M	103.29%2.82M	-20,464.63%-168.01M	-4,171.28%-8.03M	3,151.74%16.69M
Net PPE purchase and sale	--0	--0	77.10%-117K	-91.30%-44K	71.54%-37K	--0	79.55%-36K	37.45%-511K	87.77%-23K	76.23%-130K
Net investment purchase and sale	-11.72%21.26M	-5,330.49%-149.23M	144.72%69.09M	328.69%18.31M	41.78%23.85M	126.49%24.08M	103.94%2.85M	---154.5M	---8.01M	--16.82M
Net other investing changes	--0	---775K	64.69%-4.59M	----	----	----	----	---13M	--0	--0
Cash from discontinued investing activities
Investing cash flow	-11.72%21.26M	-5,424.85%-150M	138.32%64.39M	270.32%13.68M	42.66%23.82M	126.44%24.08M	103.29%2.82M	-20,464.63%-168.01M	-4,171.28%-8.03M	3,151.74%16.69M
Financing cash flow
Cash flow from continuing financing activities	808.90%2.65M	1,726.73%1.85M	100.39%231.94M	-101.79%-481K	166.15%232.02M	-85.98%292K	128.77%101K	-60.57%115.74M	7,595.25%26.83M	-70.14%87.18M
Net common stock issuance	----	----	--232.88M	---491K	----	----	----	--0	--0	----
Net preferred stock issuance	----	----	--0	--0	----	----	----	-61.46%112.22M	39,738.10%24.97M	----
Proceeds from stock option exercised by employees	556.93%2.65M	1,562.16%1.85M	-33.13%2.86M	-49.85%830K	949.31%1.51M	-82.50%404K	-32.32%111K	70.23%4.27M	95.63%1.66M	-80.62%144K
Net other financing activities	----	----	-411.29%-3.8M	-498.06%-820K	-1,262.86%-2.86M	50.22%-112K	98.06%-10K	34.79%-744K	--206K	---210K
Cash from discontinued financing activities
Financing cash flow	808.90%2.65M	1,726.73%1.85M	100.39%231.94M	-101.79%-481K	166.15%232.02M	-85.98%292K	128.77%101K	-60.57%115.74M	7,595.25%26.83M	-70.14%87.18M
Net cash flow
Beginning cash position	-13.18%184.14M	54.93%375.25M	-40.83%242.21M	62.94%413.5M	16.95%205.43M	-27.18%212.08M	-40.83%242.21M	113.10%409.37M	-42.23%253.77M	6.40%175.66M
Current changes in cash	-384.80%-32.25M	-534.44%-191.11M	179.59%133.05M	-230.76%-38.25M	166.39%208.07M	94.24%-6.65M	74.50%-30.12M	-176.94%-167.17M	61.33%-11.56M	-71.51%78.11M
End cash Position	-26.06%151.89M	-13.18%184.14M	54.93%375.25M	54.93%375.25M	62.94%413.5M	16.95%205.43M	-27.18%212.08M	-40.83%242.21M	-40.83%242.21M	-42.23%253.77M
Free cash flow	-81.03%-56.16M	-29.86%-42.96M	-41.58%-163.4M	-69.42%-51.49M	-84.64%-47.81M	-15.92%-31.02M	-2.21%-33.08M	-51.38%-115.41M	-2.87%-30.39M	-48.19%-25.89M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data